What OptiPin's sourced rule file says about Deca with Finasteride (nandrolone with a 5α-reductase inhibitor): the combination first, then what each one adds alone, then one bloodwork plan for both. It names markers and red flags, never doses.
This page describes a pair, not you. If you have chest pain, trouble breathing, weakness or numbness on one side, yellowing of your skin or eyes, or shaking, sweating and confusion that could be low blood sugar, get urgent medical care now. Nothing here is a dose, a protocol or a safety verdict.
What the rules say about the combination
1 rule fires only when both compounds are present. Each card is rendered from OptiPin's public, sourced rule file. Its labels show the evidence behind each claim (how we label evidence).
Evidence thin · mechanism, animal data or no human data
Finasteride or dutasteride with nandrolone Mechanism
Flagged by: Finasteride, Deca
5α-reductase turns nandrolone into a weaker androgen in some tissues, so blocking the enzyme may leave nandrolone's androgenic effect stronger there. That rests on receptor-binding work in rat tissue; we found no human study of the combination.
It runs opposite to how these drugs behave with testosterone, which is why the question comes up.
Evidence
Thin: mechanism from in vitro animal receptor data only; no human outcome data.
These rules fire for a single compound in the pair. They still belong in the picture, because the bloodwork for the pair is the bloodwork for both.
Organ load · each compound affects the same organ or marker; the combination is inferred
Converts to estradiol, but weakly Mechanism
Flagged by: Deca
What aromatizes here is thought to do so less than testosterone does. If the stack also suppresses your own production, estradiol can end up lower than the stack suggests.
A stack that reads as aromatizing can still leave estradiol low. In a controlled study of men, estrogen deficiency mainly raised body fat.
Markers to check
Estradiol (sensitive assay) partway through
Evidence
Low: inferred from each compound's pharmacology; no study of these stacks.
This stack suppresses your own testosterone production while it runs. Recovery after stopping usually takes 6–18 months; in one study some former long-term users still had low testosterone up to two years later.
In one study of former users, 29% had a major depressive episode during withdrawal.
Markers to check
LH, FSH and total testosterone before starting and again after stopping
How this is usually handled Clinical evidence
Low testosterone after stopping is usually managed under a clinician with a SERM such as clomiphene, hCG or testosterone therapy depending on the case; speak to a clinician.
Get medical care for
Low mood, low libido or erectile problems that persist months after stopping (see a doctor)
Evidence thin · mechanism, animal data or no human data
19-nor compound: progestin-like structure, human effect not shown Mechanism
Flagged by: Deca
Nandrolone (19-nortestosterone) is the parent structure of prescription progestins such as norethisterone and levonorgestrel. In animal receptor studies nandrolone and trenbolone bind the progesterone receptor; whether that does anything in men has not been shown.
An estradiol result does not read this receptor. We found no human study tying 19-nor use to raised prolactin, so prolactin is worth testing when symptoms appear rather than assumed.
Markers to check
Prolactin, if libido falls or the nipples change
How this is usually handled Off-label use
Anabolic users also take cabergoline off-label, often to counter suspected 19-nor side effects; whether 19-nors raise prolactin in men is not established, so test prolactin first and speak to a clinician.
Get medical care for
Nipple discharge or a tender lump behind the nipple (see a doctor)
Evidence
Thin: chemistry (the parent structure of progestins) and animal receptor binding only; no human study shows a prolactin effect. Trestolone and other 19-nors are assumed to share the structure-based activity.
Log a cycle in OptiPin and it shows whether the stack converts to estradiol, which compounds are 19-nors or 17α-alkylated, when red cell count tends to climb and when your own production is shut down, each with the marker that reads it. All on-device.
5α-reductase turns nandrolone into a weaker androgen in some tissues, so blocking the enzyme may leave nandrolone's androgenic effect stronger there. That rests on receptor-binding work in rat tissue; we found no human study of the combination. It runs opposite to how these drugs behave with testosterone, which is why the question comes up.
How is this usually handled on Deca and Finasteride?
Anabolic users also take cabergoline off-label, often to counter suspected 19-nor side effects; whether 19-nors raise prolactin in men is not established, so test prolactin first and speak to a clinician. Low testosterone after stopping is usually managed under a clinician with a SERM such as clomiphene, hCG or testosterone therapy depending on the case; speak to a clinician.
What is worth monitoring on Deca and Finasteride?
Prolactin, if libido falls or the nipples change; Estradiol (sensitive assay) partway through; LH, FSH and total testosterone before starting and again after stopping.
When should someone on Deca and Finasteride get medical care?
Nipple discharge or a tender lump behind the nipple (see a doctor); Low mood, low libido or erectile problems that persist months after stopping (see a doctor).
OptiPin